PRESENTED BY

Josua Jordi

NOMINATED BY

University of Zurich

Tags: Bye Bye Late Night Cravings, Swiss Start-ups, Pharma, Bio Tech, Metabolic Syndrome, Obesity, Appetite Supressors, First-in-class, Novel Drug Discovery Platform

EraCal Therapeutics

Switzerland

The Swiss biotech startup EraCal Therapeutics Ltd. aims to develop a novel anti-obesity drug Era-107 with demonstrated superior efficacy and tolerability compared to the standard of care in three vertebrate species – zebrafish, mice, and rat. EraCal, a spin-off from Harvard University and the University of Zurich, holds a worldwide exclusive license for the new chemical entity (patent filed Oct. 2018). An ambitious team with world-class advisors drives the development of Era-107, targeting first-in-human studies in H1/2022. Our zebrafish-based phenotypic screening platform is applicable to additional indications. EraCal secured CHF >1M in non-dilutive financing, won multiple awards (e.g. VentureKick, MIT life science angels award, IMD-startup competition, Nature SpinOff Prize finalist), and closed an oversubscribed CHF 6m seed round to finance the pre-clinical development of Era-107 and to broaden its pipeline in 2019.

More Videos (BSW)

All Videos (BSW)

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.